PortalPublikationenProgressive thrombosis in a 13-year-old girl with trisomy 21...

Progressive thrombosis in a 13-year-old girl with trisomy 21 under therapy with low molecular weight heparin.

Standard

Progressive thrombosis in a 13-year-old girl with trisomy 21 under therapy with low molecular weight heparin. / Karow, Anne; Hainmann, I; Nakamura, L; Budde, U; Mueller, C; Zieger, B.

in: KLIN PADIATR, Jahrgang 223, Nr. 3, 3, 2011, S. 180-181.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Karow, A, Hainmann, I, Nakamura, L, Budde, U, Mueller, C & Zieger, B 2011, 'Progressive thrombosis in a 13-year-old girl with trisomy 21 under therapy with low molecular weight heparin.', KLIN PADIATR, Jg. 223, Nr. 3, 3, S. 180-181. <http://www.ncbi.nlm.nih.gov/pubmed/21472634?dopt=Citation>

APA

Karow, A., Hainmann, I., Nakamura, L., Budde, U., Mueller, C., & Zieger, B. (2011). Progressive thrombosis in a 13-year-old girl with trisomy 21 under therapy with low molecular weight heparin. KLIN PADIATR, 223(3), 180-181. [3]. http://www.ncbi.nlm.nih.gov/pubmed/21472634?dopt=Citation

Vancouver

Karow A, Hainmann I, Nakamura L, Budde U, Mueller C, Zieger B. Progressive thrombosis in a 13-year-old girl with trisomy 21 under therapy with low molecular weight heparin. KLIN PADIATR. 2011;223(3):180-181. 3.

Bibtex

@article{5fd595014b4741438595b15878e1bba8,
title = "Progressive thrombosis in a 13-year-old girl with trisomy 21 under therapy with low molecular weight heparin.",
keywords = "Diagnosis, Differential, Humans, Female, Adolescent, Disease Progression, Dose-Response Relationship, Drug, Anticoagulants/adverse effects/*therapeutic use, Antibodies, Antiphospholipid/blood, Antiphospholipid Syndrome/*complications/*diagnosis, Antithrombins/adverse effects/therapeutic use, Down Syndrome/*complications/*diagnosis, Enoxaparin/adverse effects/*therapeutic use, Hirudins/adverse effects, Immunoglobulin M/blood, Recombinant Proteins/adverse effects/therapeutic use, *Renal Veins, Thrombophlebitis/*diagnosis/*drug therapy, Thrombosis/*diagnosis/*drug therapy, *Vena Cava, Inferior, beta 2-Glycoprotein I/immunology, Diagnosis, Differential, Humans, Female, Adolescent, Disease Progression, Dose-Response Relationship, Drug, Anticoagulants/adverse effects/*therapeutic use, Antibodies, Antiphospholipid/blood, Antiphospholipid Syndrome/*complications/*diagnosis, Antithrombins/adverse effects/therapeutic use, Down Syndrome/*complications/*diagnosis, Enoxaparin/adverse effects/*therapeutic use, Hirudins/adverse effects, Immunoglobulin M/blood, Recombinant Proteins/adverse effects/therapeutic use, *Renal Veins, Thrombophlebitis/*diagnosis/*drug therapy, Thrombosis/*diagnosis/*drug therapy, *Vena Cava, Inferior, beta 2-Glycoprotein I/immunology",
author = "Anne Karow and I Hainmann and L Nakamura and U Budde and C Mueller and B Zieger",
year = "2011",
language = "English",
volume = "223",
pages = "180--181",
journal = "KLIN PADIATR",
issn = "0300-8630",
publisher = "Georg Thieme Verlag KG",
number = "3",

}

RIS

TY - JOUR

T1 - Progressive thrombosis in a 13-year-old girl with trisomy 21 under therapy with low molecular weight heparin.

AU - Karow, Anne

AU - Hainmann, I

AU - Nakamura, L

AU - Budde, U

AU - Mueller, C

AU - Zieger, B

PY - 2011

Y1 - 2011

KW - Diagnosis, Differential

KW - Humans

KW - Female

KW - Adolescent

KW - Disease Progression

KW - Dose-Response Relationship, Drug

KW - Anticoagulants/adverse effects/therapeutic use

KW - Antibodies, Antiphospholipid/blood

KW - Antiphospholipid Syndrome/complications/diagnosis

KW - Antithrombins/adverse effects/therapeutic use

KW - Down Syndrome/complications/diagnosis

KW - Enoxaparin/adverse effects/therapeutic use

KW - Hirudins/adverse effects

KW - Immunoglobulin M/blood

KW - Recombinant Proteins/adverse effects/therapeutic use

KW - Renal Veins

KW - Thrombophlebitis/diagnosis/drug therapy

KW - Thrombosis/diagnosis/drug therapy

KW - Vena Cava, Inferior

KW - beta 2-Glycoprotein I/immunology

KW - Diagnosis, Differential

KW - Humans

KW - Female

KW - Adolescent

KW - Disease Progression

KW - Dose-Response Relationship, Drug

KW - Anticoagulants/adverse effects/therapeutic use

KW - Antibodies, Antiphospholipid/blood

KW - Antiphospholipid Syndrome/complications/diagnosis

KW - Antithrombins/adverse effects/therapeutic use

KW - Down Syndrome/complications/diagnosis

KW - Enoxaparin/adverse effects/therapeutic use

KW - Hirudins/adverse effects

KW - Immunoglobulin M/blood

KW - Recombinant Proteins/adverse effects/therapeutic use

KW - Renal Veins

KW - Thrombophlebitis/diagnosis/drug therapy

KW - Thrombosis/diagnosis/drug therapy

KW - Vena Cava, Inferior

KW - beta 2-Glycoprotein I/immunology

M3 - SCORING: Journal article

VL - 223

SP - 180

EP - 181

JO - KLIN PADIATR

JF - KLIN PADIATR

SN - 0300-8630

IS - 3

M1 - 3

ER -